一般人群中孕期吸烟的全国、区域和全球患病率:系统综述与荟萃分析
该系统综述与荟萃分析检索1985年1月1日至2016年2月1日文献,纳入295项研究,估算43个国家经荟萃分析、131个国家经统计建模的孕期吸烟患病率。全球孕期吸烟患病率估计为1.7%(95%CI 0.0-4.5),欧洲区域最高为8.1%(95%CI 4.0-12.2)。作者认为孕期吸烟在许多国家仍普遍,应 informing 预防规划并关注戒烟服务可及性。
要点
- 全球孕期吸烟患病率估计为1.7%(95%CI 0.0-4.5),欧洲区域为8.1%(95%CI 4.0-12.2)。
- 孕期吸烟者中72.5%(95%CI 70.4-75.0)为每日吸烟,27.5%(95%CI 25.4-29.6)为偶尔吸烟。
- 每日吸烟女性中孕期继续每日吸烟的比例为52.9%(95%CI 45.6-60.3)。
核心结论
- 孕期吸烟在许多国家仍是普遍行为,这些发现应为吸烟预防规划和健康促进策略提供依据,并引起对改善孕妇戒烟服务可及性的关注。
研究设计与样本
- 系统综述与荟萃分析,检索1985年1月1日至2016年2月1日多个电子文献数据库,无语言或地理限制,最终保留295项研究进行数据提取。
- 对有两个及以上可用实证研究的43个国家进行国家特异性随机效应荟萃分析,对有一个或无研究的131个国家使用多水平分数响应回归模型预测患病率。
- 通过计算孕期每日吸烟患病率和女性每日吸烟患病率的区域与全球平均值,估算怀孕后不戒烟的每日吸烟女性比例。
- 使用所有国家可用数据进行随机效应荟萃分析,并将相应比例应用于全球患病率估计,以估算按频率和数量的全球患病率。
- 使用单变量多水平分数响应模型进行时间趋势分析,综述方案注册号为PROSPERO CRD42017075837。
主要发现
- 孕期吸烟估计患病率最高的三个国家为爱尔兰38.4%(95%CI 25.4-52.4)、乌拉圭29.7%(95%CI 16.6-44.8)和保加利亚29.4%(95%CI 26.6-32.2)。
- 全球孕期吸烟患病率估计为1.7%(95%CI 0.0-4.5);欧洲区域为8.1%(95%CI 4.0-12.2),美洲区域为5.9%(95%CI 3.2-8.6),东南亚区域为1.2%(95%CI 0.7-1.7),西太平洋区域为1.2%(95%CI 0.0-3.7),东地中海区域为0.9%(95%CI 0.0-1.9),非洲区域为0.8%(95%CI 0.0-2.2)。
- 全球孕期吸烟女性中,72.5%(95%CI 70.4-75.0)为每日吸烟者,27.5%(95%CI 25.4-29.6)为偶尔吸烟者;51.8%(95%CI 50.0-53.5)为轻度吸烟者,34.8%(95%CI 33.1-36.4)为中度吸烟者,13.5%(95%CI 12.3-14.7)为重度吸烟者。
- 每日吸烟女性中孕期继续每日吸烟的比例为52.9%(95%CI 45.6-60.3),范围从欧洲区域的30.6%(95%CI 25.6-36.4)到西太平洋区域的79.6%(95%CI 44.2-100.0)。
临床怎么用
- 作者认为这些发现应为吸烟预防规划和健康促进策略提供依据,并引起对改善孕妇戒烟服务可及性的关注。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Smoking during pregnancy has been linked to numerous adverse health consequences for both the developing fetus and mother. We estimated the prevalence of smoking during pregnancy by country, WHO region, and globally and the proportion of pregnant women who smoked during pregnancy, by frequency and quantity, on a global level. METHODS: For this systematic review and meta-analysis, we did a comprehensive systematic literature search for studies reporting the prevalence of smoking during pregnancy in the general population, published between Jan 1, 1985 and Feb 1, 2016, using several electronic bibliographic databases (CINAHL, Embase, ERIC, Medline, Medline in process, PsychINFO, Scopus, and Web of Science), without language or geographical restrictions. We included original research studies published in a peer-reviewed journal and assessed study quality using a tool specifically developed for use in systematic reviews addressing questions of prevalence. Studies were excluded if they did not include lifetime non-smokers in their sample or estimate, used a sample not generalisable to the general population of the respective country, or did not provide primary data. To estimate the prevalence by country, we did country-specific random-effects meta-analyses for countries with two or more available empirical studies, and we predicted the prevalence using a multilevel fractional response regression model with country-specific indicators for countries with one or no study. We estimated the proportion of female daily smokers who do not quit once pregnant by calculating the regional and global averages of the prevalence of daily smoking during pregnancy and of the prevalence of daily smoking in women. To estimate the global prevalence, by frequency and quantity, we did random-effects meta-analyses using available data from all countries and applied the respective proportions to the global prevalence estimate. We did a time-trend analysis using a univariate multilevel fractional response model. The review protocol is available on PROSPERO, registration number CRD42017075837. FINDINGS: Of 21 329 studies identified, 295 were retained for data extraction. We calculated estimates via meta-analysis for 43 countries and via statistical modelling for 131 countries. The three countries with the highest estimated prevalence of smoking during pregnancy were Ireland (38·4%, 95% CI 25·4-52·4), Uruguay (29·7%, 16·6-44·8), and Bulgaria (29·4%, 26·6-32·2). The global prevalence of smoking during pregnancy was estimated to be 1·7% (95% CI 0·0-4·5). The prevalence of smoking during pregnancy was 8·1% (95% CI 4·0-12·2) in the European Region, 5·9% (3·2-8·6) in the Region of the Americas, 1·2% (0·7-1·7) in the Southeast Asian Region, 1·2% (0·0-3·7) in the Western Pacific Region, 0·9% (0·0-1·9) in the Eastern Mediterranean Region, and 0·8% (0·0-2·2) in the African Region. Globally, 72·5% (95% CI 70·4-75·0) of pregnant women who smoked were daily smokers, and 27·5% (25·4-29·6) of them were occasional smokers; 51·8% (95% CI 50·0-53·5) women who smoked were light smokers, 34·8% (33·1-36·4) were moderate smokers, and 13·5% (12·3-14·7) were heavy smokers. Furthermore, the proportion of women who smoked daily and continued to smoke daily during pregnancy was 52·9% (95% CI 45·6-60·3), ranging from 30·6% (95% CI 25·6-36·4) in the European Region to 79·6% (44·2-100·0) in the Western Pacific Region. INTERPRETATION: Smoking during pregnancy is still a prevalent behaviour in many countries. These findings should inform smoking prevention programmes and health promotion strategies, as well as draw attention to the need for improved access to smoking cessation programmes for pregnant women. FUNDING: Centre for Addiction and Mental Health.
引用
- Lange S, Probst C, Rehm J, et al. National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis. Lancet Glob Health. 2018. PMID: 29859815. doi:10.1016/S2214-109X(18)30223-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。